top of page
Maintaining Data Integrity in GMP Environments
  • Maintaining Data Integrity in GMP Environments

    This eLearning module reviews the importance of data integrity in drug manufacturing, common failures in data integrity, and the necessary steps that must be taken to ensure integrity of the data generated at pharmaceutical organizations.

     

    • Data and its attributes​

    • What is considered data​

    • What does ALCOA and ALCOA+ stand for and how does it apply to data integrity principles ​

    • Understanding common terms around data: meta data, audit trails, true copies, electronic records and electronic signatures

    • Inputs from USFDA on data integrity related queries and doubts.​

    • Consequences of data integrity non-compliance​

    • Common data integrity failures, and the reason for such  failures.​

    • Who is it for​

      Data integrity is relevant to all employees in drug product and drug substance manufacturing, quality assurance and quality control, management, supply chain, accounts, finance, and IT.​

    • Why it matters

      Consumers expect, the drugs they consume to be safe and effective. Quality and effectiveness of a drug can only be assured if its manufacturing, testing, storage and distribution have been done as per regulations. Data recorded and maintained by pharmaceutical organizations is the only means to provide evidence that regulations were followed.  Therefore, data integrity is the bedrock of GMP environments and is key to regulators’ ability to protect public health​

    AdobeStock_388497162_edited.jpg